Study reveals AI's dual impact in healthcare enhancing diagnostic accuracy by 4.4% but plummeting by 11.3% when biased, raising concerns for clinicians.
AstraZeneca taps into AI firms to build cancer antibodies to replace chemotherapy.
. Generative AI-Built Cancer Antibodies will reportedly be worked on by AstraZeneca and Absci after signing a deal approximately worth $247 million, as reported by Reuters.